Notre Dame chemists expand collaboration with Heidelberg University to include biomedical research

Author: Chontel Syfox


HeidelbergLeft to right: Markus Enders(Heidelberg University), Patricia Clark, Shahriar Mobashery, Amanda Hummon and Sharon Stack.

The Department of Chemistry and Biochemistry at the University of Notre Dame and the Faculties of Chemistry and Biosciences at Heidelberg University came together at a mini symposium on October 20 and 21 in Heidelberg, Germany.

The mini symposium discussing the interface of chemistry, biology, and medicine was a part of a larger collaboration between Notre Dame and Heidelberg, which was established in 2014 with the signing of a memorandum of understanding. The memorandum saw both institutions agreeing to explore joint research projects, student exchange, and other cooperative efforts together. According to Olaf Wiest, professor of chemistry and biochemistry who led the effort, “this was a return visit after hosting a mini symposium on catalysis at Notre Dame in 2014 and expands the collaboration into biomedical research.”

A delegation of Notre Dame chemistry and biochemistry faculty discussed their research at the mini symposium. Wiest presented ongoing drug discovery efforts on malaria and Niemann Pick Type C, Shahriar Mobashery, the Navari Family Professor in Life Sciences, discussed novel antibacterial agents; Amanda Hummon, the Huisking Foundation Associate Professor discussed imaging mass spectrometry; Patricia Clark, the Rev. John Cardinal O’Hara Professor of Biochemistry, spoke about in-vivo protein folding; and Sharon Stack, the Kleiderer-Pezold Professor of Biochemistry and director of the Harper Cancer Research Institute, shared recent research on ovarian cancer metastasis.